- Home
- IMMX vs SGRP Comparison
IMMX vs SGRP Comparison
Compare IMMX & SGRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- SGRP
- Stock Information
- Founded
- IMMX 2014
- SGRP 1967
- Country
- IMMX United States
- SGRP United States
- Employees
- IMMX N/A
- SGRP N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- SGRP Business Services
- Sector
- IMMX Health Care
- SGRP Consumer Discretionary
- Exchange
- IMMX Nasdaq
- SGRP Nasdaq
- Market Cap
- IMMX 51.1M
- SGRP 59.1M
- IPO Year
- IMMX 2021
- SGRP 1996
- Fundamental
- Price
- IMMX $1.66
- SGRP $2.48
- Analyst Decision
- IMMX Strong Buy
- SGRP
- Analyst Count
- IMMX 1
- SGRP 0
- Target Price
- IMMX $7.00
- SGRP N/A
- AVG Volume (30 Days)
- IMMX 108.3K
- SGRP 113.9K
- Earning Date
- IMMX 11-11-2024
- SGRP 11-12-2024
- Dividend Yield
- IMMX N/A
- SGRP N/A
- EPS Growth
- IMMX N/A
- SGRP N/A
- EPS
- IMMX N/A
- SGRP 0.52
- Revenue
- IMMX N/A
- SGRP $258,415,000.00
- Revenue This Year
- IMMX N/A
- SGRP N/A
- Revenue Next Year
- IMMX $200.00
- SGRP N/A
- P/E Ratio
- IMMX N/A
- SGRP $4.72
- Revenue Growth
- IMMX N/A
- SGRP N/A
- 52 Week Low
- IMMX $1.26
- SGRP $0.70
- 52 Week High
- IMMX $7.75
- SGRP $3.12
- Technical
- Relative Strength Index (RSI)
- IMMX 45.76
- SGRP 72.05
- Support Level
- IMMX $1.43
- SGRP $1.42
- Resistance Level
- IMMX $1.94
- SGRP $2.43
- Average True Range (ATR)
- IMMX 0.13
- SGRP 0.02
- MACD
- IMMX -0.01
- SGRP -0.01
- Stochastic Oscillator
- IMMX 57.97
- SGRP 100.00
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About SGRP SPAR Group Inc.
SPAR Group Inc is a supplier of merchandising and other marketing services. It also provides range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from Americas.